Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Nathrath

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Plos One|June 4, 2015
New small molecules targeting apoptosis and cell viability in osteosarcomaDoris Maugg, Ina Rothenaigner, Kenji Schorpp, et al.
The Journal of Pathology. Clinical Research|February 6, 2020
NTRK fusions in osteosarcoma are rare and non-functional eventsBaptiste Ameline, Karim H Saba, Michal Kovac, et al.
JMIR Human Factors|November 21, 2024
German Version of the Telehealth Usability Questionnaire and Derived Short Questionnaires for Usability and Perceived Usefulness in Health Care Assessment in Telehealth and Digital Therapeutics: Instrument Validation StudyJannik Zimmermann, Harriet Morf, Florian Scharf, et al.
Plos Computational Biology|November 11, 2021
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcomaMaxim Barenboim, Michal Kovac, Baptiste Ameline, et al.
Molecular Cancer|August 6, 2014
A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated miceMichael Rosemann, Iria Gonzalez-Vasconcellos, Tanja Domke, et al.
Carcinogenesis|May 23, 2002
Unbalanced overexpression of the mutant allele in murine Patched mutantsJulia Calzada-Wack, Roland Kappler, Udo Schnitzbauer, et al.
European Journal of Pediatrics|December 22, 2005
Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutationChristian Peter Kratz, Michaela Nathrath, Peter Freisinger, et al.
Cancer Metastasis Reviews|April 10, 2025
Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapyAurelie Dutour, Michela Pasello, Luke Farrow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2011
Strong expression of CXCL12 is associated with a favorable outcome in osteosarcomaDaniel Baumhoer, Jan Smida, Stephanie Zillmer, et al.
Oncotarget|December 29, 2011
CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patientsDaniel Baumhoer, Mareike Elsner, Jan Smida, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Plos One|June 4, 2015
New small molecules targeting apoptosis and cell viability in osteosarcomaDoris Maugg, Ina Rothenaigner, Kenji Schorpp, et al.
The Journal of Pathology. Clinical Research|February 6, 2020
NTRK fusions in osteosarcoma are rare and non-functional eventsBaptiste Ameline, Karim H Saba, Michal Kovac, et al.
JMIR Human Factors|November 21, 2024
German Version of the Telehealth Usability Questionnaire and Derived Short Questionnaires for Usability and Perceived Usefulness in Health Care Assessment in Telehealth and Digital Therapeutics: Instrument Validation StudyJannik Zimmermann, Harriet Morf, Florian Scharf, et al.
Plos Computational Biology|November 11, 2021
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcomaMaxim Barenboim, Michal Kovac, Baptiste Ameline, et al.
Molecular Cancer|August 6, 2014
A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated miceMichael Rosemann, Iria Gonzalez-Vasconcellos, Tanja Domke, et al.
Carcinogenesis|May 23, 2002
Unbalanced overexpression of the mutant allele in murine Patched mutantsJulia Calzada-Wack, Roland Kappler, Udo Schnitzbauer, et al.
European Journal of Pediatrics|December 22, 2005
Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutationChristian Peter Kratz, Michaela Nathrath, Peter Freisinger, et al.
Cancer Metastasis Reviews|April 10, 2025
Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapyAurelie Dutour, Michela Pasello, Luke Farrow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2011
Strong expression of CXCL12 is associated with a favorable outcome in osteosarcomaDaniel Baumhoer, Jan Smida, Stephanie Zillmer, et al.
Oncotarget|December 29, 2011
CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patientsDaniel Baumhoer, Mareike Elsner, Jan Smida, et al.
Pageof 9